Aprea Therapeutics, Inc. (APRE)
0.93
+0.03
(+3.34%)
USD |
NASDAQ |
May 21, 16:00
0.8903
-0.04
(-4.27%)
After-Hours: 19:59
Aprea Therapeutics Accounts Payable (Quarterly) : 2.941M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| United Therapeutics Corp. | 498.30M |
| Ernexa Therapeutics, Inc. | 1.30M |
| Recursion Pharmaceuticals, Inc. | 20.35M |
| Tango Therapeutics, Inc. | 2.43M |
| ACADIA Pharmaceuticals, Inc. | 12.25M |